Huang Shiyi, Chen Jiangpo, Wang Jian, Zhao Yuqi, Jin Cong, Wang Yuxiang, Lu Mengmeng, Wang Wenxuan, Qian Qingzeng, Pang Tieliang
School of Public Health, North China University of Science and Technology Tangshan 063210, Hebei, P. R. China.
Biotecnovo (Langfang) Medical Lab Co, Ltd Langfang 065000, Hebei, P. R. China.
Am J Transl Res. 2022 May 15;14(5):3311-3318. eCollection 2022.
To analyze and clarify the application value of multiplex quantitative real-time PCR (MRT-PCR) assay in detecting pathogens involved in lower respiratory tract infection (LRTI), so as to realize accurate and rapid detection of respiratory pathogens.
Bronchial alveolar lavage fluid (BALF) specimens from 186 patients with LRTI collected in the Cangzhou Central Hospital from June 2020 to September 2021 were analyzed retrospectively. Pathogen detection was performed by both MRT-PCR and direct immunofluorescence assay (DFA), and the results of different inspection methods were compared.
Among the seven pathogens detected by MRT-PCR, 140 positive specimens were identified out of the 186 patients, with the top three pathogens with the highest positive rates being influenza A virus (Flu A; 36 [19.35%]), respiratory syncytial virus (RSV; 30 [16.13%]) and human adenovirus (HAdV; 23 [12.37%]), and the pathogen with the lowest positive rate being parainfluenza virus type 3 (PIV3; 9 [4.84%]). DFA showed 110 pathogen-positive specimens, and the top three pathogens with the highest positive rates were Flu A (30 [16.13%]), HAdV (21 [11.29%]) and RSV (19 [10.22%]). The total sensitivity and accuracy of MRT-PCR assay were 93.01% and 98.69% respectively, which were statistically higher than those of 48.45% and 91.24% of DFA (P<0.05). The two inspection methods showed no significant difference in specificity (99.4% for MRT-PCR assay and 97.28% for DFA) (P>0.05).
MRT-PCR is rapid, accurate and specific in detecting pathogens of LRTI, which significantly improves the detection rate, with reliable performance and it has high clinical application value.
分析并阐明多重定量实时荧光聚合酶链反应(MRT-PCR)检测下呼吸道感染(LRTI)病原体的应用价值,以实现呼吸道病原体的准确快速检测。
回顾性分析2020年6月至2021年9月在沧州市中心医院收集的186例LRTI患者的支气管肺泡灌洗液(BALF)标本。采用MRT-PCR和直接免疫荧光法(DFA)进行病原体检测,并比较不同检测方法的结果。
在MRT-PCR检测出的7种病原体中,186例患者中有140例标本呈阳性,阳性率最高的前三种病原体为甲型流感病毒(Flu A;36例[19.35%])、呼吸道合胞病毒(RSV;30例[16.13%])和人腺病毒(HAdV;23例[12.37%]),阳性率最低的病原体为3型副流感病毒(PIV3;9例[4.84%])。DFA显示110例标本病原体呈阳性,阳性率最高的前三种病原体为Flu A(30例[16.13%])、HAdV(21例[11.29%])和RSV(19例[10.22%])。MRT-PCR检测的总灵敏度和准确性分别为93.01%和98.69%,统计学上高于DFA的48.45%和91.24%(P<0.05)。两种检测方法的特异性无显著差异(MRT-PCR检测为99.4%,DFA为97.28%)(P>0.05)。
MRT-PCR检测LRTI病原体快速、准确、特异,显著提高了检出率,性能可靠,具有较高的临床应用价值。